In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the score of a recognised scoring system?

PICO question In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the Canine Atopic Dermatitis Lesion Index score (or some other recognised scoring system)?   Clinical bottom line Category of research question Treatment The number and type of...

Celý popis

Podrobná bibliografie

Hlavní autor:	Bonnie Yuan Tone Cheung
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	RCVS Knowledge 2022-06-01
Edice:	Veterinary Evidence
Témata:	atopic dermatitis lokivetmab oclacitinib pruritus il-31 jak-kinase signalling immunomodulatory therapy canine
On-line přístup:	https://veterinaryevidence.org/index.php/ve/article/view/569
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!